This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
J

ASCO® 2024 Insights: "I-SPY2.2 Trial - Rates of pCR After Neoadjuvant Datopotamab Deruxtecan for High-Risk Stage 2/3 BC"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Jane Meisel
221 views
June 13, 2024

Chapters

I-SPY 2.2 Trial Design Overview

00:00

Dato-DXd Treatment Results & Future Plans

04:01

Comments 0
Login to view comments. Click here to Login

Featured Video

11:11
Lilly Medical Affairs

Supporting Patients With Breast Cancer in the Clinic: Setting the Pa…

Feat. S. Dawood

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy

2024 ASCO® Annual Meeting Insights Hub: Breast Videos

24:36

ASCO 2024 Highlights: Insights From Key Abstracts on mBC

2024 ASCO® Annual Meeting Insights Hub

S. Aithal

168 views

·

2 months ago
09:34

ASCO® 2024 Insights: "Impact of ctDNA Surveillance on Clinical Care …

2024 ASCO® Annual Meeting Insights Hub

M. Lipsyc-Sharf

298 views

·

3 months ago
05:06

ASCO® 2024 Insights: "Genomic Alterations in HR+/HER2- Metastatic Br…

2024 ASCO® Annual Meeting Insights Hub

M. Bhave

464 views

·

4 months ago
View All

Recommended

25:08

ASCO® 2024 Breast Cancer Highlights - Monday Morning Practice

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

4.1K views

·

5 months ago
09:55

ASCO® 2024 Insights: "The ABCs of ADCs - What Does the Future Hold?"

2024 ASCO® Annual Meeting Insights Hub

E. Hamilton

1.4K views

·

5 months ago
14:16

Year in Review: Breast Cancer

Dana-Farber Cancer Institute

P. Tarantino

2.4K views

·

9 months ago
14:52

ESMO 2024 Summary: Top 5 Breast Cancer Abstracts - NATALEE, DESTINY-…

2024 ESMO Annual Meeting Insights Hub

P. Tarantino

721 views

·

1 month ago
05:43

Neoadjuvant Chemo for HR+ BC: Year in Review

Total Health

C. Ma

975 views

·

8 months ago
36:18

Metastatic Breast Cancer Comprehensive Review: ESMO Breast 2024 Awar…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

1.2K views

·

5 months ago
33:44

ASCO® 2024 Expert Recap: "Metastatic Breast Cancer Deep Dive & Clini…

2024 ASCO® Annual Meeting Insights Hub

S. Tolaney, H. Rugo

919 views

·

4 months ago
22:34

What's New in Breast Cancer?

Dana-Farber Cancer Institute

S. Tolaney

1.5K views

·

10 months ago
10:34

ASCO® 2024 Noteworthy Abstracts in Breast Cancer

Sara Tolaney

H. Rugo

930 views

·

5 months ago
21:31

ESMO Breast 2024 Summary: "Community Oncologists Highlights"

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney, H. Rugo

1.1K views

·

5 months ago
06:10

ESMO Breast 2024 Summary: "Is There a Role for Combining ADCs With t…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

842 views

·

5 months ago
26:06

Perspectives on the Effects of Time Toxicity in Breast Cancer Treatm…

Kathryn Post

J. Hutchinson

608 views

·

1 month ago
07:50

ESMO 2023 Insights: "Real-World Use Patterns, Effectiveness, & Toler…

Oncology Data Advisor

K. Kalinsky

1.0K views

·

1 year ago
13:47

HR+ Advanced/Metastatic BC Treatment Options: Refining Endocrine Sen…

Stanford Medicine

M. Dolezal

1.1K views

·

8 months ago
10:09

ESMO Breast 2024 Insights: "Pooled Analysis of T-DXd Retreatment Aft…

Insights from ESMO Breast 2024 Annual Meeting

H. Rugo

649 views

·

5 months ago
12:55

Advances in Targeted and Endocrine Therapies for Metastatic HR+/HER2…

UChicago Medicine

N. Chen

520 views

·

4 months ago
17:35

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HER2CLIMB-0…

Insights from 2023 SABCS

P. Tarantino

1.1K views

·

11 months ago
05:35

ESMO Breast 2024 Insights: "IMpassion132 Trial - Is There a Role for…

Insights from ESMO Breast 2024 Annual Meeting

S. Tolaney

524 views

·

6 months ago
09:54

Adjuvant Abemaciclib + Endocrine Therapy for HR+, HER2- High-Risk eB…

Insights from 2023 ESMO Annual Meeting

J. Huober

1.5K views

·

11 months ago
30:46

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Insights from 2023 ESMO Annual Meeting

S. Tolaney, H. Rugo

1.1K views

·

1 year ago
AUTOPLAY